The Significance of the Effect of Visceral Adiposity on Left Ventricular Diastolic Function in the General Population

Overview

Journal Sci Rep

Specialty Science

Date 2019 Mar 16

PMID 30872595

Citations 9

Authors

Naoko Sawada

Masao Daimon

Takayuki Kawata

Tomoko Nakao

Koichi Kimura

Koki Nakanishi

Makoto Kurano

Megumi Hirokawa

Boqing Xu

Yuko Yamanaka

Tomoko S Kato

Masafumi Watanabe

Yutaka Yatomi

Issei Komuro

Affiliations

Soon will be listed here.

Abstract

We evaluated the association between visceral adiposity and left ventricular (LV) diastolic function in association with plasma adiponectin levels in 213 subjects without overt cardiac diseases. Abdominal visceral fat area was quantified by computed tomography. Excessive visceral fat was significantly associated with impaired diastolic parameters including E/A, E' and E/E'. Although serum adiponectin levels decreased with increased visceral adiposity, there was no independent association between serum adiponectin levels and diastolic parameters, which suggest that the role of adiponectin in this association might be indirect.

Citing Articles

Ratio of Skeletal Muscle Mass to Visceral Fat Area Is a Useful Marker for Assessing Left Ventricular Diastolic Dysfunction among Koreans with Preserved Ejection Fraction: An Analysis of the Random Forest Model.

Oh J, Seo Y, Hwang W, Lee S, Yoon Y, Kim K J Obes Metab Syndr. 2025; 34(1):54-64.

PMID: 39805571 PMC: 11799598. DOI: 10.7570/jomes24027.

A detailed analysis of body composition in relation to cardiopulmonary exercise test indices.

Karlsson P, Strand R, Kullberg J, Michaelsson K, Ahlstrom H, Lind L Sci Rep. 2024; 14(1):21633.

PMID: 39285239 PMC: 11405762. DOI: 10.1038/s41598-024-72973-0.

Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies.

Fu Z, Wang Y, Wang Y, Shi S, Li Y, Zhang B Lipids Health Dis. 2024; 23(1):277.

PMID: 39217346 PMC: 11365188. DOI: 10.1186/s12944-024-02266-y.

Epicardial adipose tissue volume highly correlates with left ventricular diastolic dysfunction in endogenous Cushing's syndrome.

Ran C, Su Y, Li J, Wu K, Liu Z, Yang Y Ann Med. 2024; 56(1):2387302.

PMID: 39101236 PMC: 11302473. DOI: 10.1080/07853890.2024.2387302.

Adiposity, fat-free mass and incident heart failure in 500 000 individuals.

Oguntade A, Taylor H, Lacey B, Lewington S Open Heart. 2024; 11(2).

PMID: 38964877 PMC: 11227841. DOI: 10.1136/openhrt-2024-002711.

References

. [Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome]. Nihon Naika Gakkai Zasshi. 2005; 94(4):794-809. View

Nagueh S, Smiseth O, Appleton C, Byrd 3rd B, Dokainish H, Edvardsen T . Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4):277-314. DOI: 10.1016/j.echo.2016.01.011. View

Francisco C, Neves J, Falcao-Pires I, Leite-Moreira A . Can Adiponectin Help us to Target Diastolic Dysfunction?. Cardiovasc Drugs Ther. 2016; 30(6):635-644. DOI: 10.1007/s10557-016-6694-x. View

Pou K, Massaro J, Hoffmann U, Vasan R, Maurovich-Horvat P, Larson M . Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007; 116(11):1234-41. DOI: 10.1161/CIRCULATIONAHA.107.710509. View

Ichikawa R, Daimon M, Miyazaki T, Kawata T, Miyazaki S, Maruyama M . Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2013; 12:38. PMC: 3598845. DOI: 10.1186/1475-2840-12-38. View

Unno K, Shibata R, Izawa H, Hirashiki A, Murase Y, Yamada T . Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Heart. 2009; 96(5):357-61. DOI: 10.1136/hrt.2009.172320. View

Kane G, Karon B, Mahoney D, Redfield M, Roger V, Burnett Jr J . Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011; 306(8):856-63. PMC: 3269764. DOI: 10.1001/jama.2011.1201. View

Boal F, Roumegoux J, Alfarano C, Timotin A, Calise D, Anesia R . Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity. Sci Rep. 2015; 5:16104. PMC: 4635427. DOI: 10.1038/srep16104. View

Dalzell J, Rocchiccioli J, Weir R, Jackson C, Padmanabhan N, Gardner R . The Emerging Potential of the Apelin-APJ System in Heart Failure. J Card Fail. 2015; 21(6):489-98. DOI: 10.1016/j.cardfail.2015.03.007. View

10.

Hong S, Park C, Seo H, Oh D, Ro Y . Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 2004; 13(4):236-42. DOI: 10.1080/08037050410021397. View

11.

Lee S, Daimon M, Di Tullio M, Homma S, Nakao T, Kawata T . Relationship of Left Ventricular Diastolic Function to Obesity and Overweight in a Japanese Population With Preserved Left Ventricular Ejection Fraction. Circ J. 2016; 80(9):1951-6. DOI: 10.1253/circj.CJ-16-0381. View

12.

Kenchaiah S, Evans J, Levy D, Wilson P, Benjamin E, Larson M . Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5):305-13. DOI: 10.1056/NEJMoa020245. View

13.

Lang R, Badano L, Mor-Avi V, Afilalo J, Armstrong A, Ernande L . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1):1-39.e14. DOI: 10.1016/j.echo.2014.10.003. View

14.

Wang W, McKinnie S, Patel V, Haddad G, Wang Z, Zhabyeyev P . Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues. J Am Heart Assoc. 2013; 2(4):e000249. PMC: 3828798. DOI: 10.1161/JAHA.113.000249. View

15.

Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y . Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res. 2007; 101(4):e32-42. DOI: 10.1161/CIRCRESAHA.107.158659. View

16.

McManus D, Lyass A, Ingelsson E, Massaro J, Meigs J, Aragam J . Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study. Obesity (Silver Spring). 2011; 20(9):1882-6. PMC: 3716016. DOI: 10.1038/oby.2011.32. View

17.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

18.

Ouchi N, Shibata R, Walsh K . Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006; 16(5):141-6. PMC: 2749293. DOI: 10.1016/j.tcm.2006.03.001. View

19.

Park J, Kim N, Kim S, Kim J, Kim Y, Lim H . Visceral adiposity and skeletal muscle mass are independently and synergistically associated with left ventricular structure and function: the Korean Genome and Epidemiology Study. Int J Cardiol. 2014; 176(3):951-5. DOI: 10.1016/j.ijcard.2014.08.108. View

20.

Chen W, Rijzewijk L, van der Meer R, Heymans M, van Duinkerken E, Lubberink M . Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovasc Diabetol. 2011; 10:67. PMC: 3157422. DOI: 10.1186/1475-2840-10-67. View